Calendar
Progenics Pharmaceuticals shares took a big step back on Friday after the firm announced that it received an update from the FDA.
Published:
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of a few of the biggest companies expecting clinical trial and FDA updates in February.
Published:
Last Updated:
24/7 Wall St. wanted to provide a brief outlook of this last week's economic reports and some foreshadowing for the week ahead.
Published:
Last Updated:
24/7 Wall St. has included a calendar of a some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February.
Published:
Last Updated:
24/7 Wall St. has put together a preview of GE, Intel, Verizon and other Dow Jones Industrial Average companies due to report their quarterly results this week.
Published:
Last Updated:
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Published:
Last Updated:
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
Published:
Last Updated:
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November and December.
Published:
24/7 Wall St. has collected a few more catalysts that are coming up in October for biotech and pharmaceutical companies.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
Published:
Some biopharma companies can see a massive upside just from winning a single mid-stage trial or even achieving as much as a Fast Track designation from the FDA.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts for biotech and pharmaceutical companies that are coming up in the first two months of 2017.
Published:
Last Updated:
Repros Therapeutics saw its shares take a loss on Wednesday after the company provided a key FDA update.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
Published:
Last Updated: